Cancer

In season 1, episode 2 of the popular show “The Pitt,” a Black woman with sickle cell disease arrives at the emergency department in acute pain, only to be initially dismissed as drug-seeking. “Unfortunately, this […]

Marriage, it turns out, may come with a side-effect no one puts in the vows: people who have been married seem less likely to develop cancer than those who have never married at all.This article […]

Cancer rates in Canada will remain high in 2026. Lung, breast, prostate, and colorectal cancers will be the most common, making up 47% of new diagnoses, according to research published in CMAJ (Canadian Medical Association […]

Survivors of cancer in their teen and young adult years are at double the risk of most types of later cancers, according to research from Alberta published in the Canadian Medical Association Journal. Primary neoplasms—new […]

Anemia detected in health care is associated with an increased risk of both cancer and higher mortality, according to a new population-based study from Karolinska Institutet, published in BMJ Oncology. The findings may help guide […]

A randomized trial conducted by the Alliance for Clinical Trials in Oncology has found that duloxetine, a medication commonly used to treat chronic pain and psychiatric conditions, does not prevent nerve damage caused by chemotherapy […]

In a systematic review and meta-analysis, researchers found that occupational exposure to talc that is not contaminated with asbestos is not associated with an increase in the risk of lung cancer, mesothelioma, or laryngeal cancer. […]

Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance. The study, published in the journal Immunity, […]

Leukemia is adept at dodging the immune system, making it resistant to many of the newest generation of cancer immunotherapies. Now, researchers have identified a key part of the cancer’s disguise: a protein called CD43 […]

Since 2017, a personalized immunotherapy called Chimeric Antigen Receptor, or CAR-T cell treatment, has worked wonders to treat patients with blood cancers such as leukemia. But when it comes to treating solid tumor cancers, such […]